The set up for a pump seems to be falling nicely into place, cheap, small cap, descent into oblivion, interesting tech, “undiscovered gem” feeling.
The volume is dastardly and it could still fall sub $2 before making a comeback.
They may pull a card out of their sleeve tomorrow at CareDx’s Xenotransplantation Innovation Day however it seems unlikely. It is probably a better idea to wait for news on the initiation of the phase I trials for their external liver assist program. Around that time if there is an uptick in social media buzz we may very well be in for a good ol’ pump, probably followed by an offering to fill the coffers if the stock price gains permit.
The volume is dastardly and it could still fall sub $2 before making a comeback.
They may pull a card out of their sleeve tomorrow at CareDx’s Xenotransplantation Innovation Day however it seems unlikely. It is probably a better idea to wait for news on the initiation of the phase I trials for their external liver assist program. Around that time if there is an uptick in social media buzz we may very well be in for a good ol’ pump, probably followed by an offering to fill the coffers if the stock price gains permit.